This adipokine is preferably expressed in visceral adipose tissue (visceral vascular stroma cells), which is negatively associated with insulin resistance and obesity (Herder et al., 2015), increasing the effect of insulin on the glucose metabolism (Yang et al., 2006). Here, INS is linked to obesity disorder.